Clinical Trials Sponsored by FemmePharma Global Healthcare, Inc.

Total 6 results

FemmePharma Global Healthcare, Inc.

Completed

A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence (FP1097-002)

Urinary Incontinence, Urge

United States
FemmePharma Global Healthcare, Inc.

Completed

An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic Mastalgia

Moderate to Severe Cyclic Mastalgia

United States
FemmePharma Global Healthcare, Inc.

Completed

A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease (FP1198-001)

Fibrocystic Disease of Breast

United States
Piramal Healthcare Canada Ltd
Smith & Nephew, Inc.; Global Research Solutions

Terminated

Randomized Evaluation of BST-CarGel Versus Microfracture Alone On Recovery From Distal Femoral Cartilage Lesions (RECORD)

Degenerative Lesion of Articular Cartilage of Knee | Traumatic; Lesion

Spain, France, Australia, Canada, Germany, Switzerland, United Kingdom
Pine Trees, Inc.
Piedmont Healthcare; ICON plc; MRI Global; ASCLEPES Research Center; Eastside Research... and other collaborators

Completed

A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-Care

Covid19 | SARS (Severe Acute Respiratory Syndrome)

United States
Global Alliance for TB Drug Development
Sanofi; University College, London; European and Developing Countries Clinical... and other collaborators

Completed

Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis (REMoxTB)

Pulmonary Tuberculosis

China, Zambia, Tanzania, India, Kenya, Malaysia, Mexico, South Africa, Thailand

Clinical Trials Sponsored by FemmePharma Global Healthcare, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations